Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease

Kimon Stamatelopoulos; Christine J. Pol; Colby Ayers; Georgios Georgiopoulos; Aikaterini Gatsiou; Emmanouil S Brilakis; Amit Khera; Konstantinos Drosatos; James A de Lemos; Konstantinos Stellos

doi:10.1016/j.jacc.2018.06.027

Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease

Kimon Stamatelopoulos, Christine J. Pol, Colby Ayers, Georgios Georgiopoulos, Aikaterini Gatsiou, Emmanouil S Brilakis, Amit Khera, Konstantinos Drosatos, James A de Lemos, Konstantinos Stellos

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	1060-1061
Number of pages	2
Journal	Journal of the American College of Cardiology
Volume	72
Issue number	9
DOIs	https://doi.org/10.1016/j.jacc.2018.06.027
State	Published - Aug 28 2018

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2018.06.027

Cite this

@article{f92fc09f363a435fb7aa8362af2fe1ff,

title = "Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease",

author = "Kimon Stamatelopoulos and Pol, {Christine J.} and Colby Ayers and Georgios Georgiopoulos and Aikaterini Gatsiou and Brilakis, {Emmanouil S} and Amit Khera and Konstantinos Drosatos and {de Lemos}, {James A} and Konstantinos Stellos",

note = "Funding Information: Please note: Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, ACIST, the American Heart Association (associate editor of Circulation), Amgen, Asahi, Cardiovascular Innovations Foundation (board of directors), CSI, Elsevier, GE Healthcare, Medicure, Medtronic, and Nitiloop; and has received research support from Boston Scientific and Osprey. Dr. de Lemos has received grant support from Abbott Diagnostics; and has been a consultant for Abbott Diagnostics, Roche Diagnostics, Ortho Clinical Diagnostics, and Quidel Cardiovascular, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2018",

month = aug,

day = "28",

doi = "10.1016/j.jacc.2018.06.027",

language = "English (US)",

volume = "72",

pages = "1060--1061",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "9",

}

TY - JOUR

T1 - Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease

AU - Stamatelopoulos, Kimon

AU - Pol, Christine J.

AU - Ayers, Colby

AU - Georgiopoulos, Georgios

AU - Gatsiou, Aikaterini

AU - Brilakis, Emmanouil S

AU - Khera, Amit

AU - Drosatos, Konstantinos

AU - de Lemos, James A

AU - Stellos, Konstantinos

N1 - Funding Information: Please note: Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, ACIST, the American Heart Association (associate editor of Circulation), Amgen, Asahi, Cardiovascular Innovations Foundation (board of directors), CSI, Elsevier, GE Healthcare, Medicure, Medtronic, and Nitiloop; and has received research support from Boston Scientific and Osprey. Dr. de Lemos has received grant support from Abbott Diagnostics; and has been a consultant for Abbott Diagnostics, Roche Diagnostics, Ortho Clinical Diagnostics, and Quidel Cardiovascular, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2018/8/28

Y1 - 2018/8/28

UR - http://www.scopus.com/inward/record.url?scp=85051113040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051113040&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2018.06.027

DO - 10.1016/j.jacc.2018.06.027

M3 - Letter

C2 - 30139434

AN - SCOPUS:85051113040

SN - 0735-1097

VL - 72

SP - 1060

EP - 1061

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 9

ER -

Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this